Prefilled Syringes Market, 2026 - Research and Markets

News provided by

Jan 24, 2017, 07:10 ET

DUBLIN, Jan 24, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Prefilled Syringes Market (4th Edition), 2017-2026" report to their offering.

The Prefilled Syringes Market (4th edition), 2017-2026' report provides a comprehensive analysis of the current state of prefilled syringes market and the likely future evolution of these devices over the next decade. Starting with an overview on prefilled syringes, the report elaborates on the development and manufacturing of prefilled syringes. It also includes information on needlestick injuries and provides an overview of the safety laws and legislations related to prefilled syringes across the major markets in the world.

Manufacturers have recently developed multi-chamber syringes for use with lyophilized drugs. Such syringes are also being integrated with advanced injection devices, such as autoinjectors and pen injectors. In addition, prefilled diluent syringes and flush syringes are already quite popular. With more than 60% of candidate drugs/therapies in the clinical pipeline being biologics that usually require parenteral administration, the adoption of prefilled syringes is anticipated to further increase in the mid-long term.

Some of the key objectives of the report were to enumerate the various prefilled syringe systems that are available in the market, identify the drugs that are available in such dosage forms and estimate their corresponding market potential across different geographical regions.

The study also features a detailed analysis of the existing market size and the potential future growth opportunities of these drug delivery devices across different classes of therapeutics.

The forecast takes into account the impending price variations that are likely to emerge in the mid-long term as a result of growing adoption and increased competition. In order to account for the uncertainties associated with drug development and production, we have forecasted three different market scenarios, depicting conservative, base and optimistic tracks of the industry's evolution.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Introduction to Prefilled Syringes

4. Needlestick Injuries

5. Regulatory Landscape for Prefilled Syringes

6. Growth Drivers

7. Products Available in Prefilled Syringes

8. Likely Candidates for Prefilled Syringes

9. Manufacturers of Prefilled Syringes

10. Prefilled Syringe Component Manufacturers

11. Fill-Finish Service Providers for Prefilled Syringes

12. Specialty Prefilled Syringes

13. Global Prefilled Syringes Market Forecast, 2016-2026

14. Case Study: Autoinjectors

15. Recent Developments and Applications of Prefilled Syringes

16. SWOT Analysis

17. Conclusion

18. Interview Transcripts

19. Appendix 1: Tabulated Data

20. Appendix 2: List of Companies

Companies Mentioned

3SBio
Abbott
AbbVie Biotherapeutics
AbbVie Contract Manufacturing
Ablynx
Acceleron Pharma
Accord Healthcare
AC Immune
Activa Brand Products
Adamis Pharmaceuticals Corporation
Advanced Medical Systems
AET BioTech
Aeras
Agila Biotech
Aguettant
AJ Biologics
Ajinomoto Althea
Akcea Therapeutics
Akorn
Aldagen
Alkermes
Alteogen
Adocia
Alchemia
Alder BioPharmaceuticals
Alfamatic
Allergan
Allergy Therapeutics
Allozyne
Alkermes
Almirall
Alvogen
AMEGA Biotech
Amgen
Amphastar Pharmaceuticals
AnGes
Antares Pharma
Anthera Pharmaceuticals
AOP Orphan Pharmaceuticals
Apellis Pharmaceuticals
APL Pharma
Aptar Stelmi
Apobiologix
Apotex
Aquabiliti
Araim Pharmaceuticals
Argenx
Ariston
Arte Corporation
AryoGen
Aspen Group
Astellas Pharma
AstraZeneca
Aurum Pharmaceuticals
Avesthagen
AXXO
Bahrain Pharma
Bang and Olufsen
BASF Bioresearch Corporation
Bavarian Nordic
Baxter
Bayer Healthcare
B. Braun Medical
Beacon Pharmaceuticals
Becton Dickinson
Bespak
Bharat Serums & Vaccines
BIOCAD
Biocon
BioConnection
Bio Farma
Biodel
Bio Elpida
BioGenomics
BioIncept
Bioject Medical Technologies
BioMarin Pharmaceutical
Bioneer
BioPharma Solutions
Biosidus
Biotechpharma
Biotech Visioncare
Bioviz Technologies
BioXpress Therapeutics
Blausiegel
Blau Farmacêutica
Boehringer Ingelheim BioXcellence
Bone Therapeutics
Boryung Pharmaceutical
Bracco Diagnostics
Braeburn Pharmaceuticals
BrainStorm Cell Therapeutics
Bristol Myers Squibb
Bryllan
Buender Glas
Cadila Healthcare
Cambridge Antibody Technology
Cambridge Consultants

For more information about this report visit http://www.researchandmarkets.com/research/vshx2p/prefilled

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets